Target intelligence / Profile preview

Cadherin EGF LAG seven-pass G-type receptor 1 (CELSR1)

Target
CELSR1
Molecular classification
G protein-coupled receptor, Adhesion G protein-coupled receptor, Atypical cadherin, Transmembrane receptor
01

Overview

Cadherin EGF LAG seven-pass G-type receptor 1 (CELSR1) is a neural-specific, developmentally regulated, nonclassical cadherin that acts as a core component of the planar cell polarity (PCP) pathway and is essential for the establishment of tissue polarity across epithelia and in neural development[1][4][5]. CELSR1 has a unique seven-transmembrane architecture characteristic of adhesion G protein-coupled receptors and possesses nine extracellular cadherin domains, seven EGF-like repeats, and two laminin G-like domains. It mediates homophilic cell-cell adhesion both in *cis* (on the same cell) and *trans* (between adjacent cells) via its cadherin domains, facilitating the asymmetric organization of other PCP proteins, notably Frizzled6 and Vangl2, which is crucial for processes such as neural tube closure and inner ear patterning[2][3][4][7]. Mutations in *CELSR1* can lead to severe developmental disorders, particularly neural tube defects and congenital heart disease[5]. While CELSR1 is considered a prospective therapeutic target for conditions associated with PCP dysfunction, there are currently no known drugs or clinical modulators targeting this receptor, and its endogenous ligands and downstream signaling mechanisms remain poorly characterized[5][7].

Other names
Flamingo homolog 2Cadherin family member 9Adhesion G protein-coupled receptor C1ADGRC1CDHF9FMI2HFMI2ME2LMPHM9Protocadherin flamingo 2
02

Biological functions

Cell adhesionPlanar cell polarity signalingTissue morphogenesisNeural developmentEmbryogenesisSignal transduction
03

Disease associations

Neural tube defectsCongenital heart diseaseCancerCardiovascular disease
04

Safety considerations

Unknown/undetermined due to lack of clinical dataPotential risk in developmental pathways if modulated

Beyond the preview

Go deeper on Cadherin EGF LAG seven-pass G-type receptor 1 (CELSR1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cadherin EGF LAG seven-pass G-type receptor 1 (CELSR1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call